* SHIRE - U.S. FDA GRANTS ORPHAN DRUG DESIGNATION FOR INVESTIGATIONAL SHP647 FOR TREATMENT OF PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE


10


Reuters

Latest News

Wall Street Journal: In 'Killing Eve,' a Surprising Plot Builds an Audience

Daily Mail: Domestic violence survivor reveals boyfriend's chilling threat

Daily Mail: Video: New York City will stop arresting people for smoking pot

Daily Mail: Batali divests as NY police confirm sex assault...

Daily Mail: Married At First Sight’s Telv Williams is smitten as he kisses new girlfriend Maddie Carolan 

Daily Mail: Model 3 price hype helps Tesla shares bounce

Daily Mail: Swedes told to prepare for conflict in Cold War-style...

Daily Mail: Liverpool can 'level' Real's experience with desire

Daily Mail: Donald tells Rams he's skipping OTAs

Daily Mail: 2 NYPD officers, 1 a groom on wedding day, die in crash

Daily Mail: US Postal Service issuing scratch-and-sniff stamps

Daily Mail: Lorraine Kelly looks giddy as she joins rarely-seen husband Steve Smith at Chelsea Flower Show

Daily Mail: Sydney father racially profiled by security after being falsely accused of being a paedophile

Daily Mail: South African man guilty of family axe murder that...

Daily Mail: Aguero in Atletico Madrid squad for post-season friendly with Nigeria

Daily Mail: D-Day veteran, 96, was 'hit with a claw hammer by bank card thief'

CNBC: Kudlow: ZTE push 'primarily an enforcement issue'

CNBC: Supreme Court: Worker contracts can bar class action

CNBC: News Update – Market Open

CNBC: 3 things to do if you can’t afford a down payment but still want to buy a home

CNBC: Inside the mysterious death of a 'biohacking' entrepreneur that wanted to upend the pharma business

Reuters: Soccer: Saudi Arabia feeding on scraps as they return to top table

Reuters: Soccer: Egypt aim to overturn decades of World Cup disappointment